Biocon is currently trading at RS. 354.25, down by 10.35 points or 2.84% from its previous closing of RS. 364.60 on the BSE.

The stock opened at RS. 358.55 and recorded a high of RS. 365.70 and a low of RS. 353.70 during the session. A total of 1,14,500 shares have been traded so far.

Classified under BSE group 'A', the stock with a face value of RS. 5 hit a 52-week high of RS. 405.90 on July 18, 2025, and a 52-week low of RS. 290.80 on March 3, 2025. Over the last week, it has traded between RS. 386.60 and RS. 353.60. The company’s current market capitalization stands at RS. 47896.72 crore.

The shareholding pattern shows promoters holding 54.45%, institutions holding 28.86%, and non-institutions holding 16.68%.

For the first quarter ended June 30, 2025 (Q1FY26), Biocon reported a standalone net loss of RS. 8.30 crore, compared to a net profit of RS. 0.90 crore in the same period last year. However, total income rose 8.31% to RS. 598.40 crore from RS. 552.50 crore in the corresponding quarter of the previous year.

On a consolidated basis, net profit fell sharply by 89.65% to RS. 89.20 crore in Q1FY26, compared to RS. 861.80 crore in the previous year’s same quarter. Consolidated total income declined by 11.95% to RS. 4,021.60 crore from RS. 4,567.40 crore a year earlier.